PATIENT SYMPOSIUM - THURSDAY MAY 8, 2025. HART HOUSE/VIRTUAL

8:30    Coffee

9:00    Opening Remarks - Dedicated Land acknowledgement 

9:05    Sarcoma Foundation - Patient Story
           Diana Arajs

9:30    Living with the Unknown: A Session to Manage Fear and Focus on What Matters Most
           Dr. Aliza Panjwani                

11:10  Coffee

11:30  What is the real story about sugar? What should I eat if I have cancer?
           Karmen More, RD

12:15  How do I interpret my CT results? Radiology with Patient Portals.
           Dr. David Wang   

12:45  Lunch

1:20    Has anything new happened in sarcoma trials? 
           Dr. Catherine Weadick
   
1:50    Drug access/navigation 
           Minh-Thu Nguyen, PharmD

2:20    What can you do? How to be an empowered patient!        
           Fiona Ross

3:00    Closing Remarks 
           Dr. Abha A. Gupta

3:15    Coffee/Networking


-----------------------------------------------------------------------------------------------------------------------------
​
​
​
​
SCIENTIFIC SYMPOSIUM - FRIDAY MAY 9, 2025. 1 KING WEST HOTEL/VIRTUAL
​
7:00    Meet the Professor Breakfast for trainees         
​
8:15    Opening Remarks
            Dr. Rebecca Gladdy
​
8:30    Session 1 - Pathology - Test Modalities
            Moderators: Dr. Bibiana Purgina and Bryan Lo
​
           1. Limitations of FISH vs NGS Panel 
                Dr. Bibiana Purgina and Bryan Lo
​
           2. How does transcriptomics fit? Primetime vs. research?
                 Dr. Lingxin Zhang
​
            3. Single Cell Sequencing in Osteosarcoma and Ewing sarcoma
                 Dr. Livia Garzia

            Panel Discussion – The Role of Molecular Profiling in Sarcoma
​
9:30    Session 2 - Rare Tumours (Chordoma and Angiosarcoma) 
           Moderators: Caroline Holloway and Jonathan Noujaim 
 
           1. Angiosarcoma of the breast – Primary vs. Radiation-Associated
               
               Case Presentations 
               Role of systemic therapy - Dr. Jonathan Noujaim 
               Role of radiation therapy - Dr. Caroline Holloway 
               Surgical Considerations - Dr. Sohrab Khorasani
               Cases revisited
​
            2. Chordoma 

               Case Presentation
               Protons. vs. Photons vs SBRT vs. Carbon - Dr. David Shultz
               Surgical considerations in chordoma - Dr. Ahmed Aoude
               Case revisited 
​ 
         10:30  Coffee
​
11:00  Keynote Lecture - Dr. Bill Tap
            "Sarcoma: Harnessing the Complexities of Cancer and Its Care"
   
11:45  Session 3 - What’s new in Minimally invasive therapy 
            Moderators: Dr. Peter Ferguson and Dr. Marco Fiore
 
           1. What is Percutaneous Ablation and Where is it Useful in Sarcoma?             
                Dr. John Kachura
 
             2. In vivo Lung Perfusion 
                Dr. Marcelo Cypel
 
             3. Intra-tumoural Therapy 
                Dr. Abdul Azeez Salawu
 
             4. Cryoablation in Desmoid 
               Dr. Abha A. Gupta

12:45  Lunch
 
1:30    Session 4 - Planning Surgical Margins
           Moderators: Joel Werier & Jay Wunder
 
           1. The 3D printing journey in pelvic reconstruction 
                Dr. Krista Goulding
 
            2. The Planned Positive Margin
                Dr. Kim Tsoi
​
            3. Can’t you just debulk the tumour? 
                Dr. Rebecca Gladdy

2:30    Session 5 - What’s new in LMS 
             Moderators: Dr. William Tap & Dr. Abdulazeez Salawu
​
            1. LMS: is it just one disease? 
                Dr. Olga Vornicova
             
             2. Neoadjuvant therapy in LMS: lessons learned from STRASSing
                Dr. Carol Swallow
 
             3. Local management of uterine LMS 
                Dr. Rachel Kim

3:30    Coffee
​
3:50    Rapid Fire Talks – Moderator: Dr. Joel Werier
 
4:50    Session 6 - Is there really a role for immunotherapy in sarcoma? 
             Moderators: Dr. Azeez Salwau and Dr. David Kirsch

              1. Desmoid Tumours in Pregnancy
                   Dr. Marco Fiore

                2.  Is there an Opportunity for Interrogation of Immunotherapy with Other Platforms? 
               Dr. David Kirsch

                3. Where does this leave us? 
               Dr. William Tap
 
5:30    CLOSING REMARKS – Dr. Abha Gupta and Dr. Jonathan Noujaim
 ​